61 related articles for article (PubMed ID: 8770650)
1. Development of monoclonal antibodies for the selective isolation of human plasma apolipoprotein A-containing particles.
Calvo C; Bustos P; Sepulveda J; Ulloa N; Sepulveda V
Hybridoma; 1995 Dec; 14(6):603-8. PubMed ID: 8770650
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibodies against apolipoproteins A-I and A-II. Epitope expression in LpA-I and LpA-I:A-II particles.
Ulloa N; Bustos P; Castro G; Fruchart J; Vera M; Fruchart JC; Calvo C
Hybridoma; 1999 Dec; 18(6):513-20. PubMed ID: 10626680
[TBL] [Abstract][Full Text] [Related]
3. Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux.
Oikawa S; Mendez AJ; Oram JF; Bierman EL; Cheung MC
Biochim Biophys Acta; 1993 Jan; 1165(3):327-34. PubMed ID: 8418891
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of monoclonal antibodies directed to the kringle V and protease domains of human apolipoprotein(a).
Seo YK; You KH; Kwak JW
Hybridoma; 2000 Dec; 19(6):435-44. PubMed ID: 11152395
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a monoclonal antibody (HB-22) and development of an ELISA for human apolipoprotein A-I.
Rothwell TC; Kamanna VS; Jin FY; Koren E; Foley T; Kashyap ML
Clin Chem; 1995 Aug; 41(8 Pt 1):1150-8. PubMed ID: 7628090
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to apolipoprotein AI: generation and characterization.
Falero G; Rodriguez I; Rojas A
Folia Biol (Praha); 1993; 39(1):14-22. PubMed ID: 7688698
[TBL] [Abstract][Full Text] [Related]
8. [Separation of high density lipoprotein (HDL) using anti-apo A-I, apo A-II immuno-affinity chromatography to evaluate the effects of probucol].
Kagami A; Hino K; Mochizuki K; Sakamoto T; Tada N; Ishikawa T; Manabe M; Satoh N
Nihon Ronen Igakkai Zasshi; 1991 Nov; 28(6):748-54. PubMed ID: 1795436
[TBL] [Abstract][Full Text] [Related]
9. Effect of bezafibrate on HDL with APO A-I and APO A-II and on HDL with APO A-I without APO A-II in hyperlipidaemic patients.
Branchi A; Rovellini A; Sommariva D
Int J Clin Pharmacol Res; 1995; 15(4):153-8. PubMed ID: 8871265
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody production and characterization for the measurement of plasma high density lipoprotein.
Lee SH; Cho MH
J Korean Med Sci; 1996 Oct; 11(5):390-6. PubMed ID: 8934393
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a monoclonal antibody that binds to apolipoprotein E and to lipoprotein of human plasma containing apo E. Applications to ELISA quantification of plasma apo E.
Leroy A; Vu-dac N; Koffigan M; Clavey V; Fruchart JC
J Immunoassay; 1988; 9(3-4):309-34. PubMed ID: 3235687
[TBL] [Abstract][Full Text] [Related]
12. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
[TBL] [Abstract][Full Text] [Related]
13. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to plasma high density lipoprotein (HDL) of eel (Anguilla japonica).
Ndiaye D; Katoh H; Ge YP; Iijima N; Hayashi S
Comp Biochem Physiol B Biochem Mol Biol; 2000 Apr; 125(4):473-82. PubMed ID: 10904860
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Kumar S; Isenberg DA
Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
[TBL] [Abstract][Full Text] [Related]
16. Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography.
Nanjee MN; Brinton EA
Clin Chem; 2000 Feb; 46(2):207-23. PubMed ID: 10657377
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical heterogeneity of human plasma high density lipoproteins. Identification with apolipoprotein A-I- and A-II-specific monoclonal antibodies.
Curtiss LK; Edgington TS
J Biol Chem; 1985 Mar; 260(5):2982-93. PubMed ID: 2579072
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
[TBL] [Abstract][Full Text] [Related]
19. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates.
Parra HJ; Mezdour H; Ghalim N; Bard JM; Fruchart JC
Clin Chem; 1990 Aug; 36(8 Pt 1):1431-5. PubMed ID: 2117505
[TBL] [Abstract][Full Text] [Related]
20. Development and Characterization of Monoclonal Antibodies Against Nitro-
Divya G; Jayaprakash NS; Venkataraman K
Monoclon Antib Immunodiagn Immunother; 2018 Aug; 37(4):167-174. PubMed ID: 30132720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
